Can humoral immune deficiency coexist with autoimmunity and autoreactive antibodies?

Humoral immunodeficiency—especially common variable immunodeficiency (CVID)—is not simply a state of absent antibody-mediated disease. It can combine impaired protective antibody production with immune dysregulation and autoimmune manifestations.

Clinical evidence

• Autoimmunity is a recognized feature of CVID and may precede recurrent infections. A systematic review/meta-analysis estimated autoimmune disease prevalence at 29.8% (95% CI 26.4–33.3%), with hematologic autoimmunity most frequently reported, followed by gastrointestinal and rheumatologic disease.
• Detectable autoreactive antibodies, including ANA, anti-DNA, and anticardiolipin antibodies, can occur despite hypogammaglobulinemia. Thus, reduced total IgG, IgA, and/or IgM does not make autoreactivity biologically or clinically impossible.
• Conversely, impaired antibody production can make autoantibody serology falsely negative or unreliable. Immunoglobulin replacement may further complicate interpretation. A negative antibody test therefore does not exclude autoimmune disease in this setting.

Mechanistic context

• CVID-associated autoimmunity is consistent with defective B-cell tolerance rather than uniformly absent B-cell function. Reported correlates include reduced class-switched memory B cells, impaired somatic hypermutation, and expansion of CD21^low B cells, a compartment linked to autoimmune phenotypes and autoimmune cytopenias.
• Abnormal B-cell receptor signaling, dysregulated T-cell help, and residual antibody-secreting clones provide a plausible basis for selective persistence of autoreactive specificities despite low aggregate immunoglobulin concentrations.

Clinical interpretation

• Low total immunoglobulin should not be interpreted as proof that pathogenic antibody activity is absent. However, detecting an autoantibody alone does not establish that it is disease-causing.
• Attribution requires a phenotype-consistent syndrome, an appropriate and preferably confirmed assay result, and—when feasible—supporting functional, tissue-binding, or mechanistic evidence.

Bottom line

• Humoral immunodeficiency and autoimmunity can coexist; hypogammaglobulinemia may coexist with detectable autoreactive antibodies and plausibly harmful antibody activity, but pathogenicity must be established case by case rather than inferred from antibody detection or total immunoglobulin levels alone.